| Literature DB >> 24609107 |
Richard Carciofo1, Feng Du2, Nan Song3, Kan Zhang2.
Abstract
Poor sleep quality impairs cognition, including executive functions and concentration, but there has been little direct research on the relationships between sleep quality and mind wandering or daydreaming. Evening chronotype is associated with poor sleep quality, more mind wandering and more daydreaming; negative affect is also a mutual correlate. This exploratory study investigated how mind wandering and daydreaming are related to different aspects of sleep quality, and whether sleep quality influences the relationships between mind wandering/daydreaming and negative affect, and mind wandering/daydreaming and chronotype. Three surveys (Ns = 213; 190; 270) were completed with Chinese adults aged 18-50, including measures of sleep quality, daytime sleepiness, mind wandering, daydreaming, chronotype and affect (positive and negative). Higher frequencies of mind wandering and daydreaming were associated with poorer sleep quality, in particular with poor subjective sleep quality and increased sleep latency, night-time disturbance, daytime dysfunction and daytime sleepiness. Poor sleep quality was found to partially mediate the relationships between daydreaming and negative affect, and mind wandering and negative affect. Additionally, low positive affect and poor sleep quality, in conjunction, fully mediated the relationships between chronotype and mind wandering, and chronotype and daydreaming. The relationships between mind wandering/daydreaming and positive affect were also moderated by chronotype, being weaker in those with a morning preference. Finally, while daytime sleepiness was positively correlated with daydream frequency, it was negatively correlated with a measure of problem-solving daydreams, indicating that more refined distinctions between different forms of daydreaming or mind wandering are warranted. Overall, the evidence is suggestive of a bi-directional relationship between poor sleep quality and mind wandering/daydreaming, which may be important in attempts to deal with sleep problems and improve sleep quality. These findings and further research on this topic may also have implications for definitions and theories of mind wandering and daydreaming.Entities:
Mesh:
Year: 2014 PMID: 24609107 PMCID: PMC3946719 DOI: 10.1371/journal.pone.0091285
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Psychometric properties of each scale, for each study.
|
|
|
|
|
|
|
| ||
|
| ||||||||
|
| 12–59 (12–60) | 33.51 (9.54) | .906 | .459 | .295/−.289 | .987/213/.048 | .828 | |
|
| 8–21 (4–25) | 14.76 (3.03) | .619 | .233 | −.072/−.738 | .976/213/.001 | .670 | |
|
| 0–16 (0–21) | 5.84 (2.57) | .664 | .210 | .646/.958 | .964/213/p<.0005 | .770 | |
|
| ||||||||
|
| 16–52 (12–60) | 35.66 (6.20) | .822 | .284 | −.264/.085 | .991/190/.321 | .722 | |
|
| 6–21 (4–25) | 14.48 (3.15) | .604 | .215 | −.076/−.205 | .982/190/.017 | .863 | |
|
| 0–14 (0–21) | 5.83 (2.31) | .581 | .160 | .435/.984 | .961/190/p<.0005 | .539 | |
|
| ||||||||
|
| 15–60 (12–60) | 36.16 (6.81) | .881 | .387 | .096/.992 | .986/270/.012 | .691 | |
|
| 17–60 (12–60) | 34.44 (8.82) | .865 | .365 | .294/−.373 | .985/270/.006 | .706 | |
|
| 18–60 (12–60) | 37.64 (6.56) | .849 | .329 | .339/1.153 | .982/270/.001 | − | |
|
| 6–23 (4–25) | 14.34 (2.71) | .558 | .191 | .219/.194 | .982/270/.002 | − | |
|
| 2–21 (0–24) | 11.23 (3.52) | .664 | .205 | −.074/.078 | .990/270/.053 | − | |
|
| 15–50 (10–50) | 31.37 (5.87) | .842 | .374 | .116/.373 | .990/270/.06 | .603 | |
|
| 10–46 (10–50) | 21.67 (6.56) | .856 | .373 | .775/.609 | .957/270/p<.0005 | .602 | |
|
| 1–13 (0–21) | 5.82 (2.19) | .576 | .161 | .464/.317 | .967/270/p<.0005 | .613 | |
DF = Daydream Frequency; MW = Mind Wandering; rMEQ = reduced Morningness-Eveningness Questionnaire;
PSQI Global = Global PSQI score (the sum of the seven components); PS-DD = Problem-Solving Daydreams;
ESS = Epworth Sleepiness Scale; PANAS = Positive and Negative Affect Schedule; PA = Positive Affect;
NA = Negative Affect.
Pearson, two-tailed; study 1, N = 75; study 2, N = 89; study 3, N = 171 (except MW = 73); all ps<.0005.
*Based on the seven separate components.
Chronotype classifications, and descriptive statistics by chronotype.
| Chronotype classification |
|
| |||
|
|
|
| |||
|
| |||||
|
| 33 (15.5%)(14/42.4% male) | 133 (62.4%)(44/33.1% male) | 47 (22.1%)(16/34% male) | .215** | .194** (male mean = 14.32; female = 14.99) |
|
| 24.06 (6.15) | 23.31 (5.01) | 25.74 (5.69) | − | − |
|
| 34.82 (8.38) | 34.56 (9.44) | 29.62 (9.74) | −.225** | .148* (male mean = 30.36; female = 35.19) |
|
| 6.70 (3.08) | 5.86 (2.45) | 5.17 (2.37) | (Component 6,.217**)(Component 7, −.203**) | |
|
| |||||
|
| 28 (14.7%)(9/32.1% male) | 126 (66.3%)(35/27.8% male) | 36 (18.9%)(8/22.3% male) | .211** | |
|
| 22.36 (5.88) | 23.37 (6.27) | 26.25 (8.41) | − | − |
|
| 37.04 (7.89) | 35.94 (5.86) | 33.64 (5.59) | −.143 (p = .054) | |
|
| 6.32 (2.31) | 5.87 (2.28) | 5.28 (2.37) | ||
|
| |||||
|
| 36 (13.3%)(13/36.1% male) | 201 (74.4%)(55/27.4% male) | 33 (12.2%)(6/18.2% male) | .140* (male mean = 13.69; female = 14.59) | |
|
| 19.08 (.84) | 18.89 (.74) | 18.79 (1.02) | − | − |
|
| 37.11 (8.61) | 34.2 (7.99) | 33.00 (7.89) | ||
|
| 39.14 (8.29) | 36.05 (6.14) | 33.61 (7.90) | ||
|
| 7.08 (2.32) | 5.62 (2.07) | 5.70 (2.38) | .116 (p = .063)(Component 2,.203**) | |
|
| 10.53 (3.40) | 11.46 (3.37) | 10.58 (4.42) | .113 (p = .063) (male mean = 10.58; female = 11.47) | |
|
| 38.06 (6.95) | 37.37 (6.48) | 38.82 (6.66) | ||
|
| 29.81 (5.53) | 31.20 (5.85) | 34.15 (5.60) | ||
|
| 22.61 (5.90) | 21.59 (6.80) | 21.09 (5.79) | .181** | |
See Methods section for gender differences.
Mean (standard deviation). *p≤.05; **p≤.01.
Descriptive statistics for each PSQI component for each study.
|
|
| |||||
|
|
|
|
|
|
| |
|
| 23∶50(56/21∶30–02∶30) | 23∶53(48/22∶00–02∶00) | 24∶05(40/22∶30–03∶00) | .735 | .713 | .633 |
|
| 07∶12(40/05∶00–10∶30) | 07∶20(47/05∶00–10∶00) | 07∶14(40/06∶00–10∶00) | .836 | .766 | .648 |
|
| 06∶47 (55/4.5–10) | 06∶47 (50/4.5–10) | 06∶40 (46/3.5–9) | .584 | .580 | .605 |
|
| 1.04 (.67) | 1.00 (.65) | 1.02 (.68) | .590 | .431 | .502 |
|
| .96 (.90) | .88 (.83) | .87 (.88) | .762 | .538 | .636 |
|
| .85 (.60) | .88 (.56) | .92 (.48) | .579 | .421 | .414 |
|
| .17 (.45) | .21 (.46) | .15 (.43) | .368 | .304 | .052 |
|
| .98 (.48) | .99 (.48) | .84 (.43) | .189 | .428 | .310 |
|
| .03 (.19) | .03 (.20) | .01 (.09) | − | − | −.015 |
|
| 1.81 (.87) | 1.84 (.86) | 2.02 (.76) | .505 | .591 | .488 |
|
| 5.84 (2.57) | 5.83 (2.31) | 5.82 (2.19) | .770 | .539 | .613 |
| % PSQI Global score >5 (male/female) | 49.3 (51.4/48.2) | 56.8 (57.7/56.5) | 52.2 (52.7/52) | − | − | − |
Pearson, two-tailed.
*p≤.05;
**p≤.01;
***p≤.0005.
Clock times; sd in minutes.
PSQI correlations with daydreaming, mind wandering and chronotype.
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
|
| .165 | .085 | .146 | .190 | −.507 | −.485 | −.369 |
|
| .103 | .064 | .025 | .122 | −.242 | −.234 | −.245 |
|
| −.105 | −.109 | −.028 | −.145 | .298 | .124 | .146 |
|
| .167 | .178 | .291 | .227 | −.184 | −.127 | −.108 |
|
| .202 | .255 | .167 | .272 | −.103 | −.098 | −.029 |
|
| .075 | .084 | .021 | .136 | −.265 | −.044 | −.123 |
|
| .108 | .142 | −.115 | .131 | −.028 | .069 | −.087 |
|
| .209 | .150 | .183 | .165 | −.07 | −.047 | −.023 |
|
| −.110 | −.024 | .001 | −.006 | .104 | .027 | .090 |
|
| 353 | .321 | .375 | .364 | −.262 | −.187 | −.209 |
|
| .299 | .344 | .302 | .394 | −.244 | −.145 | −.163 |
|
| −.165 | −.119 (p = .052) | −.190 | −.207 | − | − | − |
Study 1, N = 213; Study 2, N = 190; Study 3, N = 270.
*p≤.05;
** p≤.01;
*** p≤.0005.
Partial correlations, controlling for age.
‘Sleep duration’ = reported hours of sleep; ‘C3 Sleep duration’ = coded, whereby higher score = less sleep duration.
Correlations with PSQI items 5b–5j, 8 and 9.
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
|
| .146 | .103 | .140 | .116 | .041 | −.009 | .019 |
|
| .236 | .153 | −.075 | .067 | .008 | .096 | .066 |
|
| .101 | .028 | .050 | .078 | −.013 | .023 | −.083 |
|
| .027 | .064 | .001 | .105 | −.108 | −.064 | −.125 |
|
| .263 | .191 | .184 | .112 | −.105 | −.028 | −.003 |
|
| .045 | .159 | .111 | .183 | −.059 | −.089 | −.042 |
|
| .100 | .125 | .194 | .030 | −.025 | −.134 | −.029 |
|
| .177 | .013 | .160 | −.009 | −.157 | .048 | .013 |
|
| .128 | .084 | .188 | .102 | −.094 | −.078 | −.034 |
|
| .323 | .342 | .389 | .356 | −.286 | −.180 | −.213 |
|
| .319 | .281 | .303 | .396 | −.179 | −.166 | −.185 |
Study 1, N = 213; Study 2, N = 190; Study 3, N = 270.
*p≤.05;
** p≤.01;
*** p≤.0005.
Partial correlations, controlling for age.
Correlations with daytime sleepiness, positive affect, negative affect, and problem-solving daydreams.
|
|
|
|
| |
|
| −.009 | .054 | .214 | −.038 |
|
| .246 | −.081 | −.326 | .412 |
|
| .331 | −.247 | −.377 | .333 |
|
| .206 | −.044 | −.332 | .367 |
|
| − | −.214 | −.134 | .174 |
|
| − | − | .230 | .034 |
Partial correlations, controlling for age. N = 270.
*p≤.05;
**p≤.01;
***p≤.0005.
Figure 1Paths of mediation analysis.
Sleep quality as a mediator in the relationships between negative affect and daydreaming, and negative affect and mind wandering.
|
| |||||||
|
|
|
|
|
|
|
| |
|
| NA | − | DF | .418*** | − | −.037 | −.076 |
|
| NA | PSQI Global | − | .371*** | − | .048 | .035 |
|
| NA | PSQI Global | DF | .333*** | .227*** | −.048 | −.084 |
|
| |||||||
|
| |||||||
|
|
|
|
|
|
|
| |
|
| NA | − | MW | .338*** | − | .001 | −.018 |
|
| NA | PSQI Global | − | .371*** | − | .048 | .035 |
|
| NA | PSQI Global | MW | .220*** | .316*** | −.014 | −.029 |
|
| |||||||
|
| |||||||
|
|
|
|
|
|
|
| |
|
| DF | − | NA | .407*** | − | .165** | .024 |
|
| DF | PSQI Global | − | .347*** | − | .102 | .06 |
| Paths b and c’ | DF | PSQI Global | NA | .320*** | .252*** | .140 | .009 |
|
| |||||||
|
| |||||||
|
|
|
|
|
|
|
| |
|
| MW | − | NA | .328*** | − | .161** | −.002 |
|
| MW | PSQI Global | − | .393*** | − | .091 | .04 |
|
| MW | PSQI Global | NA | .219*** | .277*** | .135 | −.013 |
|
| |||||||
NA = Negative Affect; DF = Daydream Frequency; PSQI Global = PSQI Global score; MW = Mind Wandering.
Taking account of the difference between the initial and the mean indirect effect estimates.
*p≤.05; **p≤.01; ***p≤.0005.
Sleep quality as a mediator between chronotype and daydreaming, and chronotype and mind wandering.
|
| |||||||
|
|
|
|
|
|
|
| |
|
| rMEQ | − | DF | β = −.190** | − | −.184 | .185 |
|
| rMEQ | C7 | − | −.261*** | − | −.147 | .002 |
|
| rMEQ | C7 | DF | −.106 (p = .103) | .323*** | −.137 | .185** |
|
| |||||||
|
| |||||||
|
|
|
|
|
|
|
| |
|
| rMEQ | − | DF | −.110 (p = .075) | − | .034 | −.064 |
|
| rMEQ | C7 | − | −.212** | − | .041 | .021 |
|
| rMEQ | C7 | DF | −.044 (p = .463) | .311*** | .021 | −.071 |
|
| |||||||
|
| |||||||
|
|
|
|
|
|
|
| |
|
| rMEQ | − | MW | −.201** | − | −.100 | .111 |
|
| rMEQ | C7 | − | −.202** | − | −.049 | .135 |
|
| rMEQ | C7 | MW | −.132 (p = .059) | .341*** | −.083 | .065 |
|
| |||||||
|
| |||||||
|
|
|
|
|
|
|
| |
|
| rMEQ | − | MW | −.208** | − | .052 | .009 |
|
| rMEQ | C7 | − | −.212** | − | .041 | .021 |
|
| rMEQ | C7 | MW | −.138 | .335*** | .039 | .002 |
|
| |||||||
DF = Daydream frequency; MW = Mind Wandering; rMEQ = reduced Morningness-Eveningness Questionnaire;
C7 = PSQI component 7.
Taking account of the difference between the initial and the mean indirect effect estimates.
*p≤.05; **p≤.01; ***p≤.0005.
Mediation analyses for chronotype, daydream frequency, mind wandering, sleep quality and positive affect.
|
| |||||||||||
|
|
|
|
|
|
|
| Age β | Gender β | |||
|
| rMEQ | − | − | DF | −.110 | − | − | .034 | −.064 | ||
|
| rMEQ | PSQI Global | − | − | −.170 | − | − | .108 | .056 | ||
|
| rMEQ | − | PA | − | .232 | − | − | −.043 | −.128 | ||
|
| rMEQ | PSQI Global | PA | DF | −.008 (p = .897) | .266 | −.246 | −.006 | −.110 | ||
|
| |||||||||||
|
| |||||||||||
|
|
|
|
|
|
|
|
|
| |||
|
| rMEQ | − | − | MW | −.208 | − | − | .052 | .009 | ||
|
| rMEQ | PSQI Global | − | − | −.170 | − | − | .108 | .056 | ||
|
| rMEQ | − | PA | − | .232 | − | − | −.043 | −.128 | ||
|
| rMEQ | PSQI Global | PA | MW | −.098 (p = .084) | .293 | −.263 | .009 | −.041 | ||
|
| |||||||||||
|
| |||||||||||
|
|
|
|
|
|
|
|
|
| |||
|
| DF | − | − | rMEQ | −.108 | − | − | −.042 | .132 | ||
|
| DF | PSQI Global | − | − | .347 | − | − | .102 | .06 | ||
|
| DF | − | PA | − | −.335 | − | − | −.041 | −.122 | ||
|
| DF | PSQI Global | PA | rMEQ | −.008 (p = .897) | −.101 (p = .121) | .193 | −.024 | .161 | ||
|
| |||||||||||
|
| |||||||||||
|
|
|
|
|
|
|
|
|
| |||
|
| MW | − | − | rMEQ | −.204 | − | − | −.034 | .136 | ||
|
| MW | PSQI Global | − | − | .393 | − | − | .091 | .04 | ||
|
| MW | − | PA | − | −.380 | − | − | −.031 | −.103 | ||
|
| MW | PSQI Global | PA | rMEQ | −.116 (p = .084) | −.068 (p = .298) | .162 | −.023 | .156 | ||
|
| |||||||||||
Taking account of the difference between the initial and the mean indirect effect estimates.
*p≤.05;
**p≤.01;
***p≤.0005.
Moderation analysis: daydream frequency, mind wandering, chronotype and positive affect.
|
| |||||||||
|
|
|
|
|
| R |
|
|
| |
|
| −.034 | −.328*** | .019 | −.106 | − | .349 | .121 (.108) | 9.159*** (4, 265) | |
|
| −.054 | −.340*** | .024 | −.114 | .173** | .388 | .151 (.135) | 9.365*** (5, 264) | .029** |
|
| |||||||||
|
|
|
|
|
|
|
|
|
| |
|
| −.126 | −.353*** | .037 | −.036 | − | .405 | .164 (.151) | 12.981*** (4, 265) | |
|
| −.142 | −.363*** | .041 | −.042 | .133 | .426 | .181 (.166) | 11.675*** (5, 264) | .017 |
*p≤.05; **p≤.01; ***p≤.0005.